HOME > Business Wire > Article
Endo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity
Partnership enables Fujifilm Middle East FZE to distribute Endo Tools Therapeutics’ groundbreaking endomina® product range across 18 countries in Middle East and Africa (MEA)
Endo Tools Therapeutics’ minimally invasive platform provides novel endoscopic gastroplasty procedure for adults with obesity, a disease increasing in prevalence in MEA region
GOSSELIES, Belgium & DUBAI, United Arab Emirates--( BUSINESS WIRE )-- Endo Tools Therapeutics (ETT), a company developing and marketing advanced endoscopic medical devices, and Fujifilm Middle East FZE, a subsidiary of FUJIFILM Holdings Corporation, today announce their strategic partnership, to enable patients living with obesity in the Middle East and Africa to access a novel endoscopic treatment through ETT’s endomina® platform.
The platform enables endoscopists to perform a volume reduction of the stomach using a minimally invasive procedure performed via oral entry.
"Endo Tool Therapeutics’ partnership with Fujifilm is a key strategic step in our international expansion. Fujifilm’s extensive network and deep knowledge of the region make it an ideal partner to bring the benefits of endomina to a broader patient population increasingly affected by obesity," said Alexandre Chau, CEO of Endo Tools Therapeutics.
It was estimated that worldwide the number of people living with obesity had reached 890 million in 2022, a figure that has doubled over the last 30 years. In the Middle East, the prevalence of obesity is 21.2%. Obesity contributes to increased risks of comorbidities such as diabetes, cardiovascular disease and certain cancers; high rates pose serious socio-economic and health system challenges in the region1.
“We are excited to bring new, minimally invasive solutions like endomina into our portfolio. Offering innovative treatment options for patients living with obesity reflects our ongoing commitment to advancing patient care and outcomes across the region,” said Atsushi Tateishi, General Manager of Fujifilm Middle East FZE. “Through this collaboration, we aim to make meaningful advances in obesity care and improve access to cutting-edge therapies for healthcare providers and patients alike.”
About Fujifilm Middle East FZE
Fujifilm Middle East & Africa, located in Dubai, is a subsidiary of FUJIFILM Holdings Corporation, Tokyo, Japan. Fujifilm was founded in 1934 as a producer of photographic film under the name Fuji Photo Film Co. Ltd. The company has built up a wealth of advanced technologies in the field of photo imaging, and in line with its efforts to become a comprehensive healthcare company, Fujifilm is now applying these technologies to the prevention, diagnosis and treatment of diseases in the medical and life science fields. Fujifilm MEA performs its operations in medical systems, graphic systems, device technology, electronic imaging, photo imaging, optical devices, recording media and industrial products in various offices throughout the Middle East & Africa.
www.fujifilm.com/ae/en
About Endo Tools Therapeutics
Located in Gosselies, Belgium, Endo Tools Therapeutics S.A. (ETT) offers a portfolio of advanced, incisionless and minimally invasive endoscopic medical devices. The company’s mission is to develop solutions that expand the range of gastrointestinal procedures that can be performed using standard gastroscopes. By developing minimally invasive treatment solutions, ETT aims to reduce the number of complications, and the length of hospital stay for patients, and in doing so improve their comfort. The initial results from bariatric procedures performed using ETT’s soft tissue approximation devices have been published in multiple scientific articles, e.g.
GIE in 2017
,
Endoscopy in 2018
,
Gut in 2020
,
EIO in 2022
and
GIE in 2024
. Moreover, endomina is included in the joint
ASGE-ESGE guideline
on primary endoscopic bariatric and metabolic therapies.
To date, over 1,200 gastroplasty procedures have been performed using Endo Tools Therapeutics’ devices across Europe, the US and the Middle East.
In Europe the devices are approved for use in endoscopic gastroplasty procedures for the treatment of obesity, while in the US they are cleared for placement of sutures and approximation of soft tissue in the gastrointestinal tract.
www.endotools.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250630084663/en/
Contacts
Media and analyst contact
Andrew Lloyd & Associates
Celine Gonzalez
–
Carol Leslie
UK: +44 1273 952 481
US: +1 203 724 5950
Source: Endo Tools Therapeutics
Business Wire
-
07/18 02:00 AGC Launches Innovative Fluoroelastomer Without the Use of Surfactants...
-
07/18 00:00 Aeris and Bridge Alliance Extend Partnership to Offer the World’s Fi...
-
07/17 23:11 UL Solutions to Help Companies in Japan Meet New Climate Disclosure St...
-
07/17 15:00 Keysight Introduces an Enhanced Electromagnetic Interference Test Rece...
-
07/17 14:00 Elix Provides AI Drug Discovery Platform “Elix Discovery™” to Ei...
-
07/17 13:16 Globalstar Begins Major Expansion of Ground Station in Bihoro, Japan t...
-
07/17 12:30 Asahi Kasei’s Microza® Hollow Fiber Membrane for Filtration and Sep...
-
07/17 12:00 SBC Medical Group Acquires MB Career Lounge: “JUN CLINIC” Joins th...
-
07/17 12:00 ENHERTU® Plus Pertuzumab Granted Breakthrough Therapy Designation in ...
-
07/17 08:30 Hyundai Glovis Partners with Lab021 to Deploy ‘Vessellink’
-
07/17 06:30 Lattice and Mitsubishi Electric Collaborate to Deliver Next-Gen Indust...
-
07/17 06:00 The world’s Leading! The World Premier Show for Cameras, Photography...
-
07/17 02:00 Toshiba Releases Automotive Photorelay with 1800V Output Withstand Vol...
-
07/17 00:01 NIPPON KINZOKU Launches New Sales Expansion of Die Wear-Resistant Stai...
-
07/17 00:00 Kobelco Construction Machinery Digitally Transforms Demand and Supply ...
-
07/17 00:00 From Seattle to Chiba: Okayama University Taps AGC Biologics' Global P...
-
07/16 15:36 JCR Pharmaceuticals Selected for Japan’s Regenerative Medicine CDMO ...
-
07/16 14:00 SkyDrive to Perform Further Demonstrations Flights at Osaka Expo2025
-
07/15 21:00 GSSG Chikuden Launches with US$400M Commitment from Vision Ridge Partn...
-
07/15 14:00 Elix and LINC Become the First in the World to Commercialize an AI Dru...
-
07/15 11:00 JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration ...
-
07/15 10:09 “We Bloom!” in Hualien
-
07/15 02:00 FPT Achieves Select Tier Partnership with Databricks, Strengthening It...
-
07/14 13:00 Japan's Car Industry Has Highest Robot Installations in Five Years
-
07/14 08:04 CORRECTING and REPLACING KATE, Japan’s No. 1 Makeup Brand, Launches ...
-
07/14 07:00 Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of ...
-
07/11 02:00 Toyoda Gosei Invests in Helical Fusion, a Startup for Clean Nuclear Fu...
-
07/11 02:00 Helical Fusion Raises JPY 2.3 Billion Series A, Advances Roadmap for W...
-
07/11 01:00 DNP to Open First Overseas R&D Center in the Netherlands
-
07/10 10:45 XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in M...